| View |
|
DRP-10773
|
Levothyroxine Sodium
|
Euthyrox
|
50 mcg
|
Tablet
|
-
|
Merck Healthcare KGAA
|
Germany
|
-
|
17 November 2021
|
17 November 2026
|
| View |
|
DRP-10764
|
Levothyroxine Sodium
|
Euthyrox
|
150 mcg
|
Tablet
|
-
|
Merck Healthcare KGAA
|
Germany
|
-
|
17 November 2021
|
17 November 2026
|
| View |
|
DR-XY47513
|
Ivabradine (as hydrochloride)
|
None
|
5 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
17 November 2021
|
17 November 2026
|
| View |
|
DRP-8443-02
|
Digoxin
|
Dicore
|
250 mcg/mL
|
Solution For Injection (IM/IV)
|
-
|
Samarth Life Sciences Pvt. Ltd.
|
India
|
-
|
18 November 2021
|
15 August 2026
|
| View |
|
DR-XY47530
|
Sitagliptin (as phosphate)
|
Trevia
|
100mg
|
Film-Coated Tablet
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Initial
|
15 November 2021
|
15 November 2026
|
| View |
|
DR-XY47529
|
Sitagliptin (as phosphate)
|
Trevia
|
50mg
|
Film-Coated Tablet
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Initial
|
15 November 2021
|
15 November 2026
|
| View |
DRP-10613_PI_01.pdf
|
DRP-10613
|
Febuxostat
|
Fevorica 80
|
80 mg
|
Film-Coated Tablet
|
-
|
Acme Formulation Pvt. Ltd.
|
India
|
-
|
16 November 2021
|
16 November 2026
|
| View |
DR-XY44106_PIL_01.pdf
|
DR-XY44106
|
Guaifenesin+Phenylephrine+Chlorphenamine Maleate
|
Pleuragex
|
100mg/5mg/2mg per 5 mL
|
Syrup
|
-
|
San Marino Laboratories, Corporation
|
Philippines
|
-
|
15 November 2021
|
26 January 2025
|
| View |
|
DRP-10614
|
Febuxostat
|
Stabufost 80
|
80 mg
|
Film-Coated Tablet
|
-
|
Acme Formulation Pvt. Ltd.
|
India
|
-
|
16 November 2021
|
16 November 2026
|
| View |
|
DRP-10774
|
Mupirocin
|
Mupicin
|
20 mg/ g (2%)
|
Topical Cream
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
17 November 2021
|
17 November 2026
|
| View |
|
BR-1380
|
Human Immunoglobulin
|
Pentaglobin
|
50 mg/ mL
|
Solution for Infusion (IV)
|
-
|
Biotest AG
|
Germany
|
-
|
16 November 2021
|
16 November 2026
|
| View |
|
DRP-5843-02
|
Levofloxacin (as Hemihydrate)
|
Levopak
|
500 mg
|
Film Coated Tablet
|
-
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
-
|
08 November 2021
|
01 December 2024
|
| View |
|
DR-XY47541
|
Moxifloxacin (Hydrochloride)
|
Avelox
|
400 mg/ 250 mL
|
Solution For IV Infusion
|
-
|
Fresenius Kabi Italia S.R.L.
|
Italy
|
-
|
18 November 2021
|
18 November 2026
|
| View |
|
DRP-463
|
Methylergometrine Maleate
|
Mergotrex
|
200 mcg/mL
|
Solution for Injection (I.M./Slow I.V.)
|
-
|
Panpharma GmbH
|
Germany
|
-
|
15 November 2021
|
30 March 2025
|
| View |
|
DRP-10683
|
Gliclazide
|
Saphclazide-60
|
60 mg
|
Modified-Release Tablet
|
Blood glucose lowering drug (Sulfonylurea)
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
11 November 2021
|
11 November 2026
|
| View |
DR-XY321_PIL_01.pdf
|
DR-XY321
|
Sodiumcitrate+Dextromethorphan+Chlorphenamine Maleate
|
Pleuragex-DM
|
150mg/15mg/2mg per 5mL
|
Syrup
|
-
|
San Marino laboratories Corporation
|
Philippines
|
-
|
15 November 2021
|
03 March 2025
|
| View |
|
DRP-5663
|
Mebendazole
|
Unbranded
|
100 mg/5 mL
|
Suspension
|
Anthelmintic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
02 November 2024
|
24 May 2030
|
| View |
|
DR-XY29479
|
Biperiden Hydrochloride
|
None
|
2 mg
|
Tablet
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
15 November 2021
|
29 March 2025
|
| View |
|
DRP-5776
|
Iron + Folic Acid
|
Folicure
|
65 mg (equivalent to 200 mg ferrous sulfate)
250 mcg
|
Capsule
|
Hematinic
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Renewal
|
27 October 2024
|
17 April 2030
|
| View |
|
DRP-5550
|
Iron
|
None
|
44 mg (equivalent to 220 mg Ferrous Sulfate)/5 mL
|
Syrup
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
19 November 2021
|
12 May 2025
|